Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-01T02:32:00.078Z Has data issue: false hasContentIssue false

Whey protein concentrate ameliorates the methotrexate-induced liver and kidney damage

Published online by Cambridge University Press:  23 March 2023

Elif Tufan
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
Güzin Göksun Sivas
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
Begüm Gürel-Gökmen
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
Sümeyye Yılmaz-Karaoğlu
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
Ercan Dursun
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
Esin Çalışkan-Ak
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Histology and Embryology Department, İstanbul, Turkey
Aleyna Muhan
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Histology and Embryology Department, İstanbul, Turkey
Dilek Özbeyli
Affiliation:
Marmara University, Faculty of Vocational School of Health Services, İstanbul, Turkey
Göksel Şener
Affiliation:
Fenerbahçe University, Faculty of Pharmacy, Pharmacology Department, İstanbul, Turkey
Tuğba Tunali-Akbay*
Affiliation:
Marmara University, Faculty of Dentistry, Basic Medical Sciences, Biochemistry Department, İstanbul, Turkey
*
*Corresponding Author, Tugba Tunali-Akbay, email: ttunali@marmara.edu.tr

Abstract

Methotrexate (MTX) is a cytotoxic immunosuppressant that is widely used in the treatment of tumours, rheumatoid arthritis and psoriasis. This study aims to evaluate the effects of whey proteins on MTX-induced liver and kidney damage by focusing on oxidant–antioxidant systems and eating habits. The study was conducted in four groups of thirty Sprague–Dawley rats (control, control + whey protein concentrate (WPC), MTX, MTX + WPC). A single dose of 20 mg/kg MTX was administered intraperitoneally to the MTX groups. Control and MTX groups were given 2 g/kg WPC by oral gavage every day for 10 d. At the end of day 10, blood samples were drawn and liver and kidney tissues were removed. MTX administration increased the lipid peroxidation level and decreased glutathione level, superoxide dismutase and glutathione-S-transferase activities in the liver and kidney. Administration of WPC significantly reduced the damage caused by MTX in the liver and kidney. While a decrease in serum urea level and an increase in serum creatinine level were detected in the MTX group, WPC administration reversed these results up to control group levels. Administration of WPC to the MTX group significantly reversed the histopathological damage scores of the liver and kidney. WPC administration ameliorated the MTX-induced oxidative damage in the liver and kidney tissues due to its antioxidant properties. Liver and kidney damage can be prevented by using whey proteins as a nutraceutical in MTX therapy. In conclusion, whey proteins demonstrated a protective effect against MTX-induced liver and kidney damage.

Type
Research Article
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Puig, L (2014) Methotrexate: new therapeutic approaches. Actas Dermosifiliogr 105, 583589.10.1016/j.ad.2012.11.017CrossRefGoogle ScholarPubMed
Saka, S & Aouacheri, O (2017) The investigation of the oxidative stress-related parameters in high doses methotrexate-induced albino Wistar rats. J Bioequiv Availab 9, 372376.Google Scholar
Mager, DR (2015) Methotrexate. Home Healthc Now 33, 139141.10.1097/NHH.0000000000000203CrossRefGoogle ScholarPubMed
Walker, T, Rhodes, P & Westmoreland, C (2000) The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol Vitro 14, 475485.10.1016/S0887-2333(00)00036-9CrossRefGoogle ScholarPubMed
Uraz, S, Tahan, V, Aygun, C, et al. (2008) Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci 53, 10711077.10.1007/s10620-007-9949-3CrossRefGoogle ScholarPubMed
Widemann, BC & Adamson, PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11, 694703.10.1634/theoncologist.11-6-694CrossRefGoogle ScholarPubMed
Savran, M, Cicek, E, Doguc, D, et al. (2017) Vitamin C attenuates methotrexate-induced oxidative stress in the kidney and liver of rats. Physiol Int 104, 139149.10.1556/2060.104.2017.2.5CrossRefGoogle Scholar
Mann, B, Athira, S, Sharma, R, et al. (2019) Bioactive peptides from whey proteins. In Whey Proteins from Milk to Medicine, pp. 519547 [Hilton C. Deeth and Nidhi Bansal, editors]. USA: Academic Press.10.1016/B978-0-12-812124-5.00015-1CrossRefGoogle Scholar
Brandelli, A, Daroit, DJ & Corrêa, APF (2015) Whey as a source of peptides with remarkable biological activities. Food Res Intl 73, 149161.10.1016/j.foodres.2015.01.016CrossRefGoogle Scholar
Barone, G, Moloney, C, O’Regan, J, et al. (2020) Chemical composition, protein profile and physicochemical properties of whey protein concentrate ingredients enriched in α-lactalbumin. J Food Comp Anal 92, 103546.10.1016/j.jfca.2020.103546CrossRefGoogle Scholar
Tonolo, F, Folda, A, Cesaro, L, et al. (2020) Milk-derived bioactive peptides exhibit antioxidant activity through the Keap1-Nrf2 signaling pathway. J Funct Foods 64, 103696.10.1016/j.jff.2019.103696CrossRefGoogle Scholar
Layman, DK, Lönnerdal, B & Fernstrom, JD (2018) Applications for α-lactalbumin in human nutrition. Nutr Rev 76, 444460.10.1093/nutrit/nuy004CrossRefGoogle ScholarPubMed
Khaire, RA & Gogate, PR (2019) Whey proteins. In Proteins: Sustainable Source, Processing and Applications, pp. 193223 [Charis M. Galanakis, editor]. USA: Academic Press.10.1016/B978-0-12-816695-6.00007-6CrossRefGoogle Scholar
Mansour, DF, Salama, AA, Hegazy, RR, et al. (2017) Whey protein isolate protects against cyclophosphamide-induced acute liver and kidney damage in rats. J Appl Pharm Sci 7, 111120.Google Scholar
Athira, S, Mann, B, Sharma, R, et al. (2013) Ameliorative potential of whey protein hydrolysate against paracetamol-induced oxidative stress. J Dairy Sci 96, 14311437.10.3168/jds.2012-6080CrossRefGoogle ScholarPubMed
Moodi, H, Hosseini, M, Abedini, MR, et al. (2020) Ethanolic extract of Iris songarica rhizome attenuates methotrexate-induced liver and kidney damages in rats. Avicenna J Phytomed 10, 372.Google ScholarPubMed
Fouad, A, Hafez, H & Hamouda, A (2020) Hydrogen sulfide modulates IL-6/STAT3 pathway and inhibits oxidative stress, inflammation, and apoptosis in rat model of methotrexate hepatotoxicity. Hum Exp Toxicol 39, 7785.10.1177/0960327119877437CrossRefGoogle ScholarPubMed
Aslankoc, R, Ozmen, O & Ellidag, HY (2020) Ameliorating effects of agomelatine on testicular and epididymal damage induced by methotrexate in rats. J Biochem Mol Toxicol 34, e22445.10.1002/jbt.22445CrossRefGoogle ScholarPubMed
Rizk, FH, Saadany, AAE, Dawood, L, et al. (2018) Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone. J Inflamm Res 11, 421429.10.2147/JIR.S178767CrossRefGoogle ScholarPubMed
Azadnasab, R, Kalantar, H, Khorsandi, L, et al. (2021) Epicatechin ameliorative effects on methotrexate-induced hepatotoxicity in mice. Hum Exp Toxicol 40, S603S610.10.1177/09603271211047924CrossRefGoogle ScholarPubMed
Shimizu, Y, Hara, H & Hira, T (2021) Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats. Br J Nutr 125, 398407.10.1017/S0007114520002834CrossRefGoogle ScholarPubMed
Radic, I, Mijovic, M, Tatalovic, N, et al. (2019) Protective effects of whey on rat liver damage induced by chronic alcohol intake. Hum Exp Toxicol 38, 632645.10.1177/0960327119829518CrossRefGoogle ScholarPubMed
Rosenthal, HL (1955) Determination of urea in blood and urine with diacetyl monoxime. Anal Chem 27, 19801982.10.1021/ac60108a039CrossRefGoogle Scholar
Slot, C (1965) Plasma creatinine determination a new and specific Jaffe reaction method. Scand J Clin Lab Invest 17, 381387.10.3109/00365516509077065CrossRefGoogle ScholarPubMed
Ledwozyw, A, Michalak, J, Stepień, A, et al. (1986) The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta; Int J Clin Chem 155, 275283.10.1016/0009-8981(86)90247-0CrossRefGoogle ScholarPubMed
Miranda, KM, Espey, MG & Wink, DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5, 6271.10.1006/niox.2000.0319CrossRefGoogle ScholarPubMed
Beutler, E (1984) Red Cell Metabolism: A Manual of Biochemical Methods. Orlando, FL: Grune & Stratton.Google Scholar
Habig, WH & Jakoby, WB (1981) Assays for differentiation of glutathione S-Transferases. In Methods in Enzymology 77, pp. 398405. USA: Academic Press.Google Scholar
Mylroie, AA, Collins, H, Umbles, C, et al. (1986) Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 82, 512520.10.1016/0041-008X(86)90286-3CrossRefGoogle ScholarPubMed
Ingram, G (1976) Reference method for the one stage prothrombin time test on human blood. Thromb Haemostas 36, 237–238.Google Scholar
Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.10.1038/227680a0CrossRefGoogle ScholarPubMed
Shinde, CG, Venkatesh, M, Kumar, TP, et al. (2014) Methotrexate: a gold standard for treatment of rheumatoid arthritis. J Pain Palliat Care Pharmacother 28, 351358.10.3109/15360288.2014.959238CrossRefGoogle Scholar
Chan, ES & Cronstein, BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res Ther 4, 18.Google ScholarPubMed
Boukhettala, N, Leblond, J, Claeyssens, S, et al. (2009) Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab 296, E182E190.10.1152/ajpendo.90459.2008CrossRefGoogle ScholarPubMed
Leblond, J, Le Pessot, F, Hubert-Buron, A, et al. (2008) Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med 233, 219228.10.3181/0702-RM-49CrossRefGoogle ScholarPubMed
Sinno, MH, Coquerel, Q, Boukhettala, N, et al. (2010) Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration. Physiol Behav 101, 639648.10.1016/j.physbeh.2010.09.016CrossRefGoogle ScholarPubMed
Fox, AD, Kripke, SA, De Paula, J, et al. (1988) Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J Parenter Enteral Nutr 12, 325331.10.1177/0148607188012004325CrossRefGoogle ScholarPubMed
Jahovic, N, Cevik, H, Sehirli, AO, et al. (2003) Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 34, 282287.10.1034/j.1600-079X.2003.00043.xCrossRefGoogle ScholarPubMed
Asci, H, Ozmen, O, Ellidag, HY, et al. (2017) The impact of gallic acid on the methotrexate-induced kidney damage in rats. J Food Drug Anal 25, 890897.10.1016/j.jfda.2017.05.001CrossRefGoogle ScholarPubMed
Moghadam, AR, Tutunchi, S, Namvaran-Abbas-Abad, A, et al. (2015) Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress. BMC Complement Altern Med 15, 113.10.1186/s12906-015-0773-6CrossRefGoogle ScholarPubMed
Bedoui, Y, Guillot, X, Sélambarom, J, et al. (2019) Methotrexate an old drug with new tricks. Int J Mol Sci 20, 5023.10.3390/ijms20205023CrossRefGoogle ScholarPubMed
Li, X, Abe, E, Yamakawa, Y, et al. (2016) Effect of administration duration of low dose methotrexate on development of acute kidney injury in rats. J Kidney 2, 3.10.4172/2472-1220.1000130CrossRefGoogle Scholar
Olayinka, ET, Ore, A, Adeyemo, OA, et al. (2016) Ameliorative effect of gallic acid on methotrexate-induced hepatotoxicity and nephrotoxicity in rat. J Xenobiot 6, 6092.10.4081/xeno.2016.6092CrossRefGoogle ScholarPubMed
Özgöçmen, M & Yeşilot, Ş (2021) The role of resveratrol in hepatotoxicity caused by methotrexate. Vet J Mehmet Akif Ersoy Uni 6, 5763.10.24880/maeuvfd.922106CrossRefGoogle Scholar
Yuksel, Y, Yuksel, R, Yagmurca, M, et al. (2017) Effects of quercetin on methotrexate-induced nephrotoxicity in rats. Hum Exp Toxicol 36, 5161.10.1177/0960327116637414CrossRefGoogle ScholarPubMed
Cetinkaya, A, Kurutas, EB, Bulbuloglu, E, et al. (2007) The effects of N-acetylcysteine on methotrexate-induced oxidative renal damage in rats. Nephrol Dial Transplant 22, 284285.10.1093/ndt/gfl420CrossRefGoogle ScholarPubMed
Abdel-Daim, MM, Khalifa, HA, Abushouk, AI, et al. (2017) Diosmin attenuates methotrexate-induced hepatic, renal, and cardiac injury: a biochemical and histopathological study in mice. Oxid Med Cell Longev 2017, 3281670.10.1155/2017/3281670CrossRefGoogle ScholarPubMed
Mehrzadi, S, Fatemi, I, Esmaeilizadeh, M, et al. (2018) Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomed Pharmacother 97, 233239.10.1016/j.biopha.2017.10.113CrossRefGoogle ScholarPubMed
Butenas, S (2012) Tissue factor structure and function. Science 2012, 964862.Google ScholarPubMed
Tousson, E, Zaki, ZT, Abu-Shaeir, WA, et al. (2014) Methotrexate-induced hepatic and renal toxicity: role of L-carnitine in treatment. Biomed Biotechnol 2, 8592.Google Scholar
Jafaripour, L, Naserzadeh, R, Alizamani, E, et al. (2021) Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in Wistar rats. Indian J Nephrol 31, 218.Google ScholarPubMed
Budancamanak, M, Kanter, M, Demirel, A, et al. (2006) Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis. Arch Toxicol 80, 768776.10.1007/s00204-006-0094-0CrossRefGoogle ScholarPubMed
Faisal, R, Shinwari, L & Jehangir, T (2015) Comparison of the therapeutic effects of thymoquinone and methotrexate on renal injury in pristane induced arthritis in rats. J Coll Phys Surg Pak 25, 597601.Google ScholarPubMed
Severin, MJ, Campagno, RV, Brandoni, A, et al. (2019) Time evolution of methotrexate-induced kidney injury: a comparative study between different biomarkers of renal damage in rats. Clin Exp Pharmacol Physiol 46, 828836.10.1111/1440-1681.13122CrossRefGoogle ScholarPubMed